Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background and objective: Early detection of colon adenomas at high risk of progression and early-stage colorectal cancer (CRC) is an effective approach to reduce CRC death rates. Current screening methods lack specificity as they detect many adenomas that will never progress to CRC. The authors aimed to identify cell surface protein biomarkers with extracellular domains that could be targeted for molecular imaging and discriminate low-risk adenomas and normal colon from high-risk adenomas and CRC. Design: Cell surface proteins of five CRC cell lines were biotinylated, isolated and analysed by in-depth proteomics using gel electrophoresis and nanoliquid chromatography coupled to tandem mass spectrometry. Differential expression in adenomas and CRCs was based on mRNA expression and verified by immunohistochemical staining of tissue microarrays. Results: In total, 2609 proteins were identified in the cell surface fractions. Of these, 44 proteins were selected as promising cell surface candidate biomarkers for adenoma-to-carcinoma progression based on the following criteria: protein identification in at least four out of five cell lines, a predicted (trans)membrane location and increased mRNA expression in CRCs compared to adenomas. Increased protein expression in high-risk adenomas and CRCs compared to low-risk adenomas was confirmed by immunohistochemistry for glucose transporter type 1 (gene symbol SLC2A1 ; p<0.00001) and prion protein (gene symbol PRNP ; p<0.005). Conclusion: This study revealed glucose transporter type 1, prion protein and 42 other cell surface candidate biomarkers for adenoma-to-carcinoma progression that could potentially serve as targets for emerging molecular imaging modalities like optical imaging, 19 F-MRI and positron emission tomography.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Microsatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
Cited by
Implications of peptide assemblies in amyloid diseases
Ke, P. C., Sani, M.-A., Ding, F., Kakinen, A., Javed, I., Separovic, F., Davis, T. P., & Mezzenga, R. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00372b · Cited by 338
Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma
Wiśniewski, J. R., Ostasiewicz, P., Duś, K., Zielińska, D. F., Gnad, F., & Mann, M. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.44 · Cited by 248
“4 Molecular Systems Biology 2012 & 2012 EMBO and Macmillan Publishers Limited Additionally, elevated expression of proteins involved in cell-cycle regulation in C and M reflects higher cell division rates of cancer cells in comparison with normal cells (Figure 2N).”
BackgroundMethodInfluentialA Raman-based endoscopic strategy for multiplexed molecular imaging
Zavaleta, C. L., Garai, E., Liu, J. T. C., Sensarn, S., Mandella, M. J., Van de Sompel, D., Friedland, S., Van Dam, J., Contag, C. H., & Gambhir, S. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211309110 · Cited by 238
Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery
PosthumaDeBoer, J., Piersma, S. R., Pham, T. V., van Egmond, P. W., Knol, J. C., Cleton-Jansen, A. M., van Geer, M. A., van Beusechem, V. W., Kaspers, G. J. L., van Royen, B. J., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.578 · Cited by 73
“…Isolation Kit (ThermoScientific, Waltham, MA, USA), following the manufacturer’s instructions adjusted according to the protocol described by De Wit et al (2012) (Figure 1A); Supplementary File S1 provides an elaborate description of the cell surface protein isolation and mass spectrometry…”
MethodSelf-citationCSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression
Sillars-Hardebol, A. H., Carvalho, B., Beliën, J. A. M., de Wit, M., Delis-van Diemen, P. M., Tijssen, M., van de Wiel, M. A., Pontén, F., Meijer, G. A., & Fijneman, R. J. A. (2012) · Cellular Oncology · doi:10.1007/s13402-012-0088-2 · Cited by 38
Self-citation
Metadata
- Authors
- de Wit, M., Jimenez, C. R., Carvalho, B., Belien, J. A. M., Delis-van Diemen, P. M., Mongera, S., Piersma, S. R., Vikas, M., Navani, S., Pontén, F., Meijer, G. A., & Fijneman, R. J. A.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2011-09-02
- Volume
- 61
- Issue
- 6
- Pages
- 855-864
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2100370963
- Cited by
- 76
- References
- 2
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression. https://app.cochat.ai/papers/10.1136/gutjnl-2011-300511
- The paper
- de Wit, M., Jimenez, C. R., Carvalho, B., Belien, J. A. M., Delis-van Diemen, P. M., Mongera, S., Piersma, S. R., Vikas, M., Navani, S., Pontén, F., Meijer, G. A., & Fijneman, R. J. A. (2012). Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression. Gut. https://doi.org/10.1136/gutjnl-2011-300511
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.